Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Universal Health's (UHS) Q4 Earnings Surpass, Improve Y/Y

Published 02/26/2020, 10:28 PM
Updated 07/09/2023, 06:31 AM
US500
-
ELV
-
UNH
-
HCA
-
UHS
-

Universal Health Services Inc. (NYSE:UHS) delivered fourth-quarter 2019 adjusted earnings of $2.79 per share, beating the Zacks Consensus Estimate by 6.9%. Moreover, the bottom line increased 17.7% year over year on the back of higher revenues.

In the quarter under review, revenues increased 5.1% year over year to $2.9 billion and also exceeded the Zacks Consensus Estimate by 0.3%, backed by higher admissions and patient days.

Total operating expenses of $2.5 billion at the end of the fourth quarter increased 2.4% year over year due to higher salaries, wages and benefits, supplies expense, and depreciation and amortization expenses.

Segmental Update

Acute Care Hospitals:


Adjusted admissions and adjusted patient days rose 2.1% and 6%, respectively, from the prior-year quarter. Net revenues (on same-facility basis) climbed 7.9% in the fourth quarter, majorly aided by higher admissions and patient days.

Behavioral Hospitals:

On same-facility basis, adjusted admissions inched up 0.8% while adjusted patient days were up 0.9%, both on a year-over-year basis. Net revenues too were up 4.5% year over year on same-facility basis.

Financial Update

As of Dec 31, 2019, the company had cash and cash equivalents of $61.3 million, down 41.8% from the level at 2018 end.

Total assets were $11.6 billion as of Dec 31, 2019, up 3.6% from the 2018-end figure.

The company’s long-term debt came in at $3.9 billion, down 1% from the level at 2018 end.

For 2019, net cash provided by operating activities came in at $1.4 billion, up 12.8% year over year. This was on the back of improvement in net income plus/minus depreciation and amortization expense, stock-based compensation expense, provision for asset impairment and net gains on sale of assets and costs related to extinguishment of debt, favorable change in accrued and deferred income taxes as well as net favorable changes.

Buyback Program

In the fourth quarter, the company bought back shares worth $181.2 million.

In July 2019, the company’s board of directors increased its share buyback plan by $1 billion.

Full-Year Highlights

For 2019, the company’s net income came in at $9.13 per share, up 9.9% year over year.

Net revenues for 2019 were up 5.6% year over year to $11.4 billion.

2020 Guidance

Following fourth-quarter results, the company gave its 2020 outlook.

Net revenues for the current year are anticipated between $11.96 billion and $12.11 billion.

Adjusted EPS per share is expected in the band of $10.30-$11. Management projects capital expenditures between $775 million and $825 million.

Zacks Rank

Universal Health currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Releases From the Medical Sector

Among other medical sector players that already reported fourth-quarter earnings, the bottom-line results of UnitedHealth Group Incorporated (NYSE:UNH) and HCA Healthcare, Inc. (NYSE:HCA) beat estimates while that of Anthem Inc. (NYSE:ANTM) missed the consensus mark.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.

This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.

See their latest picks free >>



UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

Universal Health Services, Inc. (UHS): Free Stock Analysis Report

HCA Healthcare, Inc. (HCA): Free Stock Analysis Report

Anthem, Inc. (ANTM): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.